Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 May 31;12(5):953-956.
doi: 10.21037/tlcr-23-68. Epub 2023 Apr 7.

Towards a clinically applicable histomolecular classification of lung adenocarcinomas?

Anne-Laure Désage  1 , Tiphanie Picot  2 , Fabien Forest  2   3
Affiliations
Editorial

Towards a clinically applicable histomolecular classification of lung adenocarcinomas?

Anne-Laure Désage et al. Transl Lung Cancer Res. .
No abstract available

Keywords: EGFR; KRAS; Lung; adenocarcinoma; subtyping.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://tlcr.amegroups.com/article/view/10.21037/tlcr-23-68/coif). The authors have no conflicts of interest to declare.

Comment on

  • Clin Cancer Res. 28:3824.

References

    1. WHO. Classification of Tumors Editorial Board Thoracic Tumors. 5th edition. Lyon: International Agency for Research on Cancer, 2021.
    1. Pelosi G, Scarpa A, Forest F, et al. The impact of immunohistochemistry on the classification of lung tumors. Expert Rev Respir Med 2016;10:1105-21. 10.1080/17476348.2017.1235975 - DOI - PubMed
    1. Casteillo F, Guy JB, Dal-Col P, et al. Pathologic Subtypes of Lung Adenocarcinoma Brain Metastasis Is a Strong Predictor of Survival After Resection. Am J Surg Pathol 2018;42:1701-7. 10.1097/PAS.0000000000001161 - DOI - PubMed
    1. Da Cruz V, Yvorel V, Casteillo F, et al. Histopathological subtyping is a prognostic factor in stage IV lung adenocarcinoma. Lung Cancer 2020;147:77-82. 10.1016/j.lungcan.2020.07.010 - DOI - PubMed
    1. Perret R, Chalabreysse L, Watson S, et al. SMARCA4-deficient Thoracic Sarcomas: Clinicopathologic Study of 30 Cases With an Emphasis on Their Nosology and Differential Diagnoses. Am J Surg Pathol 2019;43:455-65. 10.1097/PAS.0000000000001188 - DOI - PubMed

Publication types